Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesFaes Farma SA

Faes Farma SA

PortfolioPortfolio WatchlistWatchlist
Company price
None GBX 0.00(0%)
Last update at 2026-10-28T03:28:52.050580Z
Market Cap
1047.34M

Momentum Score

…

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. The company also provides animal nutrition and health products. It offers products for various therapeutic areas. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
3.60
Low
5.45
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Faes Farma SA is a Spain-based pharmaceutical company that develops, manufactures and markets prescription medicines, generics and consumer healthcare products for domestic and export markets. Long-term growth may be supported by its product pipeline, manufacturing scale and geographic expansion, and investors may find the company attractive for a diversified portfolio and in-house production capabilities.

Material risks include regulatory and pricing pressure, dependence on a limited number of products or markets, R&D and pipeline execution uncertainty, and currency and input-cost exposure that investors should monitor.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.68
Dividend Yield
-
Revenue TTM
626.99M
Revenue Per Share
2.01
Gross Profit TTM
399.98M
Debt / Equity
0.00
ROE
10.82%
Net Debt
-
ROCE
21.26%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - 84.88M 74.17M 61.73M
Net income - - 72.55M 63.96M 51.59M
Selling general administrative - - 107.11M 105.25M 95.90M
Gross profit - - 239.84M 227.41M 204.13M
Ebit 101.92M 97.11M 92.31M 78.83M 62.01M
Operating income - - 86.77M 74.86M 61.97M
Other operating expenses 85.66M 76.53M 52.82M 53.28M 49.14M
Interest expense - 0.00M 0.00M 0.00M 0.00M
Tax provision - - 11.51M 10.15M 9.93M
Interest income - - 2.04M 0.74M 0.32M
Income tax expense 11.92M 10.52M 11.51M 10.15M 9.93M
Total revenue - - 380.24M 357.40M 324.31M
Cost of revenue - - 140.40M 129.99M 120.18M
Net income applicable to common shares 89.55M 82.39M 72.55M 63.96M 51.59M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets - - 564.15M 493.67M 471.20M
Intangible assets - - 112.88M 106.99M 111.74M
Other current assets 0.52M 0.36M 0.38M 0.54M 0.33M
Total liab - - 92.75M 80.70M 111.32M
Total stockholder equity - - 471.39M 412.97M 359.88M
Deferred long term liab 23.16M 20.30M 15.91M 12.37M 9.63M
Other current liab 10.47M 9.51M 12.54M 8.69M 2.06M
Common stock 31.08M 29.74M 28.52M 27.82M 27.01M
Retained earnings 588.22M 510.36M 446.50M 385.75M 332.95M
Other liab 20.80M 22.81M 18.86M 1.37M 3.18M
Good will - - 52.64M 61.50M 53.94M
Other assets 143.66M 70.17M 53.43M 30.49M 35.65M
Cash - - 91.21M 52.85M 76.04M
Total current liabilities 94.43M 79.31M 84.69M 72.28M 103.75M
Short long term debt total - - 1.65M 3.18M 0.89M
Other stockholder equity -14.41M -0.48M 0.18M 3.20M 3.73M
Property plant equipment 108.14M 117.78M 88.13M 81.50M 61.93M
Total current assets 313.21M 293.71M 290.01M 222.99M 217.58M
Net tangible assets 445.55M 373.35M 321.78M 254.73M 203.84M
Short term investments - - 1.93M 1.33M 0.37M
Net receivables 113.59M 112.49M 104.91M 96.81M 81.54M
Long term debt - - 0.06M 0.38M 0.89M
Inventory 115.00M 107.45M 91.59M 71.45M 59.30M
Accounts payable 36.59M 37.92M 41.97M 37.74M 35.64M
Treasury stock - - -5.26M -5.26M -5.26M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - -18.68M -1.88M -0.60M
Change to liabilities - - 1.18M -6.86M 4.67M
Total cashflows from investing activities - - -92.17M -83.48M -25.78M
Net borrowings - - -0.31M -3.40M -2.71M
Total cash from financing activities - - -18.46M -17.12M -14.35M
Change to operating activities - - -2.28M -5.42M -1.97M
Net income 111.36M 91.90M 89.55M 82.39M 72.55M
Change in cash - - -3.84M -20.96M 38.36M
Total cash from operating activities - - 106.79M 79.64M 78.49M
Depreciation - - 18.46M 16.53M 14.28M
Other cashflows from investing activities - - 0.25M 0.02M 0.16M
Dividends paid - - 7.44M 4.93M 4.24M
Change to inventory - - -8.80M -10.83M -20.85M
Change to account receivables - - -1.10M -3.80M -11.38M
Sale purchase of stock - - - - -0.09M
Other cashflows from financing activities - - - - 0.46M
Change to netincome - - 8.97M 6.91M 20.65M
Capital expenditures 0.00M 0.00M 75.22M 51.49M 20.21M
Change in working capital - - - - -35.49M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

Faes Farma SA

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. The company also provides animal nutrition and health products. It offers products for various therapeutic areas. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

Avenida AutonomIa 10, Leioa, Spain, 48940

34 944 81 83 00

https://faesfarma.com

1775

Name Title Year Born
Mr. Mariano Ucar Angulo Chairman of Directors NA
Mr. Gonzalo Fernández de Valderrama Iribarnegaray Sec. of the Board of Directors NA
Mr. Eduardo Recoder de la Cuadra CEO & Executive Director NA
Mr. Valentín Ruiz Unamunzaga Chief Financial Officer NA
Isabel Najera Chief Scientific & Medical Officer NA
Ms. Maria Marin Head of Investor Relations & External Communication NA
Mr. Alberto Fernández Fernández Chief Marketing & Portfolio Strategy Officer NA
Mr. Carlos Gutierrez Aguero Chief People Officer NA
Mr. Xavier Arnaud Chief Business Development Officer NA
Mr. Jose Luis Diaz Capote Chief International Business Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…